Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-53.45	4.76	-10.23
Graham Fair Price	41.42	0.41	0.29
PEG	-73.23	-0.03	0.13
Price/Book	-0.42	0.55	0.56
Price/Cash Flow	45.53	-8.43	-15.48
Prices/Earnings	50.21	-3.48	-6.99
Price/Sales	-50.21	1.35	2.71
Price/FCF	45.53	-8.43	-15.48
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.11	0.11
Operating Margin	0.00	-0.09	-0.09
ROA	-100.00	-0.02	-0.01
ROE	-0.02	-0.04	-100.00
ROIC	-0.02	-0.04	-89.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	2.62	-0.78	233.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.64	-1.00	56.00
EPS QOQ	0.54	-1.00	86.00
FCF QOQ	0.39	-0.83	109.98
Revenue QOQ	-0.52	1.00	91.09
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-65.50	-32.75	50.00
Days Sales Outstanding (DSO)	393.25	206.05	-47.60
Inventory Turnover	-1.37	-2.75	-100.00
Debt/Capitalization	< 0.005	< 0.005	259.57
Quick Ratio	1.44	2.11	46.58
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.43	0.43	< 0.005
Cash	0.17	0.40	144.86
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	-0.02	-0.03	-82.83
Revenue	0.09	0.18	100.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.12	2.12	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.08	22.49	12.01
Naive Interpretation	Member

06 - Financial Health · Bad

Rating